Aslan Pharmaceuticals Ltd logo

Aslan Pharmaceuticals Ltd Share Price (NASDAQ: ASLN)

▲

-0.6

(-100%)

Last updated on

Bell Icon

The stock has been delisted from the stock exchange on 18 Jul 2024

Check the interactive Aslan Pharmaceuticals Ltd Stock chart to analyse performance

Aslan Pharmaceuticals Ltd Key Stats

Check Aslan Pharmaceuticals Ltd key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$0.6
Open
$0.63
Market Capitalization
$1.7M
Today's Volume
$803.5K
Revenue TTM
$12.0M
EBITDA
$-34.9M
Earnings Per Share (EPS)
$-16.0
Profit Margin
-291.89%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-426.64%

Global Institutional Holdings in Aslan Pharmaceuticals Ltd

  • Name

    Holdings %

Analyst Recommendation on Aslan Pharmaceuticals Ltd Stock

Rating
Trend

Buy

    87%Buy

    12%Hold

    0%Sell

Based on 8 Wall street analysts offering stock ratings for Aslan Pharmaceuticals Ltd(by analysts ranked 0 to 5 stars)

About Aslan Pharmaceuticals Ltd

ASLAN Pharmaceuticals Limited, a clinical-stage immunology focused biopharmaceutical company, engages in developing various treatments to transform the lives of patients. The company's clinical portfolio comprises eblasakimab (ASLAN004), a monoclonal antibody that targets the IL-13 receptor a1 subunit which is under Phase 2 developed for the treatment of atopic dermatitis and other immunology indications; and farudodstat (ASLAN003), an orally active, potent inhibitor of human dihydroorotate dehydrogenase currently under Phase 2 clinical trials for the treatment of autoimmune diseases. It has research collaboration agreement with Zenyaku Kogyo Co., Ltd. for the development and commercialization of eblasakimab in atopic dermatitis and all other indications in Japan. The company was founded in 2010 and is headquartered in Singapore.
Organization
Aslan Pharmaceuticals Ltd
Employees
35
CEO
Dr. Carl Alan Jason Morton Firth EMBA, Ph.D.
Industry
Health Technology

Important FAQs about investing in ASLN Stock from India :

What is Aslan Pharmaceuticals Ltd share price today?

Aslan Pharmaceuticals Ltd share price today is as on at the close of the market. Aslan Pharmaceuticals Ltd share today touched a day high of {{1_rba_end}} and a low of {{1_rba_st}}.

What is the 52 week high and 52 week low for Aslan Pharmaceuticals Ltd share?

Aslan Pharmaceuticals Ltd share touched a 52 week high of {{rba_end}} and a 52 week low of {{rba_st}}. Aslan Pharmaceuticals Ltd stock price today i.e. is closed at , lower by 100% versus the 52 week high.

How to invest in Aslan Pharmaceuticals Ltd Stock (ASLN) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Aslan Pharmaceuticals Ltd on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Aslan Pharmaceuticals Ltd Shares .

What is the minimum amount required to buy Aslan Pharmaceuticals Ltd Stock (ASLN) from India?

Indian investors can start investing in Aslan Pharmaceuticals Ltd (ASLN) shares with as little as ₹88.019 or $1 (as of September 09, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹880.19 in Aslan Pharmaceuticals Ltd stock (as per the Rupee-Dollar exchange rate as on September 09, 2025). Learn more about fractional shares .

What are the returns that Aslan Pharmaceuticals Ltd has given to Indian investors in the last 5 years?

Aslan Pharmaceuticals Ltd stock has given 0.0% share price returns and 19.35% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?